Loading…
Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loade...
Saved in:
Published in: | Pharmaceutics 2019-10, Vol.11 (11), p.559 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3 |
container_end_page | |
container_issue | 11 |
container_start_page | 559 |
container_title | Pharmaceutics |
container_volume | 11 |
creator | Shukla, Snehal K Kulkarni, Nishant S Chan, Amanda Parvathaneni, Vineela Farrales, Pamela Muth, Aaron Gupta, Vivek |
description | This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loaded lipid film. The drug-loaded film method exhibited maximum entrapment efficiency (~65%) as compared to active loading (~25%) and passive loading (~5%) prepared Met-loaded liposomes. The therapeutic efficacy of these optimized liposomes was evaluated for cellular uptake, cytotoxicity, inhibition of metastatic activity, and apoptosis-inducing activity. Results demonstrated significantly superior activity of positively charged liposomes resulting in reduced IC
values, minimal cell migration activity, reduced colony formation, and profound apoptosis-induced activity in breast cancer cells as compared to Met. The anti-tumor activity was investigated using a clinically relevant in vitro tumor simulation model, which confirmed enhanced anti-tumorigenic property of liposomal Met over Met itself. To the authors' knowledge, this is the first report of Met-loaded liposomes for improving the efficacy and therapeutic effect of Met against breast cancer. With the results obtained, it can be speculated that liposomal encapsulation of metformin offers a potentially promising and convenient approach for enhanced efficacy and bioavailability in breast cancer treatment. |
doi_str_mv | 10.3390/pharmaceutics11110559 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_46b6bfc7d4f3493fb47416177968c295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_46b6bfc7d4f3493fb47416177968c295</doaj_id><sourcerecordid>2550227844</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3</originalsourceid><addsrcrecordid>eNptkk1v1DAQhi0EolXpTwBF4sIl4K84MQekZVmg0iIOlLPlj_FuVkkcbKfS_ntctlQtYi5jz7zzaGY0CL0k-C1jEr-b9zqO2sKSe5tIMdw08gk6J1LKmkvKnj54n6HLlA64GGOkY_I5OmNECCJ5e478N8g-xLGf6s1k9ZyWQWdw1bafQwojVJ9g6G8gHqsfx5RhfF-tpmrjPdhcwtV1BJ1HmHK1mucYtN1Xeqf7KeXqY0kVt9aThfgCPfN6SHB55y_Qz8-b6_XXevv9y9V6ta1tg5tcU-Fa5zAlDqyltz9JQFOtjTOYlO6dBCepYxgwdN44YYiRHAxg0nWNYxfo6sR1QR_UHPtRx6MKuld_AiHulI5laQMoLoww3raOe8Yl84a3nAjStlJ0lsqmsD6cWPNiRnC2TBn18Aj6ODP1e7ULN0pIirtOFsCbO0AMvxZIWY19sjAMeoKwJEUZwUJ0raBF-vof6SEscSqrUrRpMKVtx3lRNSeVjSGlCP6-GYLV7WGo_x5GqXv1cJL7qr9nwH4DKf25sQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2550227844</pqid></control><display><type>article</type><title>Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer</title><source>NCBI_PubMed Central(免费)</source><source>Publicly Available Content (ProQuest)</source><creator>Shukla, Snehal K ; Kulkarni, Nishant S ; Chan, Amanda ; Parvathaneni, Vineela ; Farrales, Pamela ; Muth, Aaron ; Gupta, Vivek</creator><creatorcontrib>Shukla, Snehal K ; Kulkarni, Nishant S ; Chan, Amanda ; Parvathaneni, Vineela ; Farrales, Pamela ; Muth, Aaron ; Gupta, Vivek</creatorcontrib><description>This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loaded lipid film. The drug-loaded film method exhibited maximum entrapment efficiency (~65%) as compared to active loading (~25%) and passive loading (~5%) prepared Met-loaded liposomes. The therapeutic efficacy of these optimized liposomes was evaluated for cellular uptake, cytotoxicity, inhibition of metastatic activity, and apoptosis-inducing activity. Results demonstrated significantly superior activity of positively charged liposomes resulting in reduced IC
values, minimal cell migration activity, reduced colony formation, and profound apoptosis-induced activity in breast cancer cells as compared to Met. The anti-tumor activity was investigated using a clinically relevant in vitro tumor simulation model, which confirmed enhanced anti-tumorigenic property of liposomal Met over Met itself. To the authors' knowledge, this is the first report of Met-loaded liposomes for improving the efficacy and therapeutic effect of Met against breast cancer. With the results obtained, it can be speculated that liposomal encapsulation of metformin offers a potentially promising and convenient approach for enhanced efficacy and bioavailability in breast cancer treatment.</description><identifier>ISSN: 1999-4923</identifier><identifier>EISSN: 1999-4923</identifier><identifier>DOI: 10.3390/pharmaceutics11110559</identifier><identifier>PMID: 31661947</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>3d spheroids ; ampk activation ; Breast cancer ; Cancer therapies ; Chemotherapy ; Drug dosages ; Entrapment ; Homeostasis ; Hydration ; Kinases ; Lipids ; liposomes ; metformin</subject><ispartof>Pharmaceutics, 2019-10, Vol.11 (11), p.559</ispartof><rights>2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3</citedby><cites>FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3</cites><orcidid>0000-0002-3618-8178</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2550227844/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2550227844?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31661947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shukla, Snehal K</creatorcontrib><creatorcontrib>Kulkarni, Nishant S</creatorcontrib><creatorcontrib>Chan, Amanda</creatorcontrib><creatorcontrib>Parvathaneni, Vineela</creatorcontrib><creatorcontrib>Farrales, Pamela</creatorcontrib><creatorcontrib>Muth, Aaron</creatorcontrib><creatorcontrib>Gupta, Vivek</creatorcontrib><title>Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer</title><title>Pharmaceutics</title><addtitle>Pharmaceutics</addtitle><description>This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loaded lipid film. The drug-loaded film method exhibited maximum entrapment efficiency (~65%) as compared to active loading (~25%) and passive loading (~5%) prepared Met-loaded liposomes. The therapeutic efficacy of these optimized liposomes was evaluated for cellular uptake, cytotoxicity, inhibition of metastatic activity, and apoptosis-inducing activity. Results demonstrated significantly superior activity of positively charged liposomes resulting in reduced IC
values, minimal cell migration activity, reduced colony formation, and profound apoptosis-induced activity in breast cancer cells as compared to Met. The anti-tumor activity was investigated using a clinically relevant in vitro tumor simulation model, which confirmed enhanced anti-tumorigenic property of liposomal Met over Met itself. To the authors' knowledge, this is the first report of Met-loaded liposomes for improving the efficacy and therapeutic effect of Met against breast cancer. With the results obtained, it can be speculated that liposomal encapsulation of metformin offers a potentially promising and convenient approach for enhanced efficacy and bioavailability in breast cancer treatment.</description><subject>3d spheroids</subject><subject>ampk activation</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Drug dosages</subject><subject>Entrapment</subject><subject>Homeostasis</subject><subject>Hydration</subject><subject>Kinases</subject><subject>Lipids</subject><subject>liposomes</subject><subject>metformin</subject><issn>1999-4923</issn><issn>1999-4923</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1v1DAQhi0EolXpTwBF4sIl4K84MQekZVmg0iIOlLPlj_FuVkkcbKfS_ntctlQtYi5jz7zzaGY0CL0k-C1jEr-b9zqO2sKSe5tIMdw08gk6J1LKmkvKnj54n6HLlA64GGOkY_I5OmNECCJ5e478N8g-xLGf6s1k9ZyWQWdw1bafQwojVJ9g6G8gHqsfx5RhfF-tpmrjPdhcwtV1BJ1HmHK1mucYtN1Xeqf7KeXqY0kVt9aThfgCPfN6SHB55y_Qz8-b6_XXevv9y9V6ta1tg5tcU-Fa5zAlDqyltz9JQFOtjTOYlO6dBCepYxgwdN44YYiRHAxg0nWNYxfo6sR1QR_UHPtRx6MKuld_AiHulI5laQMoLoww3raOe8Yl84a3nAjStlJ0lsqmsD6cWPNiRnC2TBn18Aj6ODP1e7ULN0pIirtOFsCbO0AMvxZIWY19sjAMeoKwJEUZwUJ0raBF-vof6SEscSqrUrRpMKVtx3lRNSeVjSGlCP6-GYLV7WGo_x5GqXv1cJL7qr9nwH4DKf25sQ</recordid><startdate>20191028</startdate><enddate>20191028</enddate><creator>Shukla, Snehal K</creator><creator>Kulkarni, Nishant S</creator><creator>Chan, Amanda</creator><creator>Parvathaneni, Vineela</creator><creator>Farrales, Pamela</creator><creator>Muth, Aaron</creator><creator>Gupta, Vivek</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3618-8178</orcidid></search><sort><creationdate>20191028</creationdate><title>Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer</title><author>Shukla, Snehal K ; Kulkarni, Nishant S ; Chan, Amanda ; Parvathaneni, Vineela ; Farrales, Pamela ; Muth, Aaron ; Gupta, Vivek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>3d spheroids</topic><topic>ampk activation</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Drug dosages</topic><topic>Entrapment</topic><topic>Homeostasis</topic><topic>Hydration</topic><topic>Kinases</topic><topic>Lipids</topic><topic>liposomes</topic><topic>metformin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shukla, Snehal K</creatorcontrib><creatorcontrib>Kulkarni, Nishant S</creatorcontrib><creatorcontrib>Chan, Amanda</creatorcontrib><creatorcontrib>Parvathaneni, Vineela</creatorcontrib><creatorcontrib>Farrales, Pamela</creatorcontrib><creatorcontrib>Muth, Aaron</creatorcontrib><creatorcontrib>Gupta, Vivek</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shukla, Snehal K</au><au>Kulkarni, Nishant S</au><au>Chan, Amanda</au><au>Parvathaneni, Vineela</au><au>Farrales, Pamela</au><au>Muth, Aaron</au><au>Gupta, Vivek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer</atitle><jtitle>Pharmaceutics</jtitle><addtitle>Pharmaceutics</addtitle><date>2019-10-28</date><risdate>2019</risdate><volume>11</volume><issue>11</issue><spage>559</spage><pages>559-</pages><issn>1999-4923</issn><eissn>1999-4923</eissn><abstract>This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loaded lipid film. The drug-loaded film method exhibited maximum entrapment efficiency (~65%) as compared to active loading (~25%) and passive loading (~5%) prepared Met-loaded liposomes. The therapeutic efficacy of these optimized liposomes was evaluated for cellular uptake, cytotoxicity, inhibition of metastatic activity, and apoptosis-inducing activity. Results demonstrated significantly superior activity of positively charged liposomes resulting in reduced IC
values, minimal cell migration activity, reduced colony formation, and profound apoptosis-induced activity in breast cancer cells as compared to Met. The anti-tumor activity was investigated using a clinically relevant in vitro tumor simulation model, which confirmed enhanced anti-tumorigenic property of liposomal Met over Met itself. To the authors' knowledge, this is the first report of Met-loaded liposomes for improving the efficacy and therapeutic effect of Met against breast cancer. With the results obtained, it can be speculated that liposomal encapsulation of metformin offers a potentially promising and convenient approach for enhanced efficacy and bioavailability in breast cancer treatment.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>31661947</pmid><doi>10.3390/pharmaceutics11110559</doi><orcidid>https://orcid.org/0000-0002-3618-8178</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1999-4923 |
ispartof | Pharmaceutics, 2019-10, Vol.11 (11), p.559 |
issn | 1999-4923 1999-4923 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_46b6bfc7d4f3493fb47416177968c295 |
source | NCBI_PubMed Central(免费); Publicly Available Content (ProQuest) |
subjects | 3d spheroids ampk activation Breast cancer Cancer therapies Chemotherapy Drug dosages Entrapment Homeostasis Hydration Kinases Lipids liposomes metformin |
title | Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A53%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metformin-Encapsulated%20Liposome%20Delivery%20System:%20An%20Effective%20Treatment%20Approach%20against%20Breast%20Cancer&rft.jtitle=Pharmaceutics&rft.au=Shukla,%20Snehal%20K&rft.date=2019-10-28&rft.volume=11&rft.issue=11&rft.spage=559&rft.pages=559-&rft.issn=1999-4923&rft.eissn=1999-4923&rft_id=info:doi/10.3390/pharmaceutics11110559&rft_dat=%3Cproquest_doaj_%3E2550227844%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2550227844&rft_id=info:pmid/31661947&rfr_iscdi=true |